Early Microascus cinereus endocarditis of a prosthetic valve implanted after Staphylococcus aureus endocarditis of the native valve.
Célard
M
M
Laboratoire de Microbiologie, Service de Cardiologie, Hôpital Louis Pradel, Lyon, France. cardibac@laennec.univ-lyon1.fr
Dannaoui
E
E
Piens
M A
MA
Guého
E
E
Kirkorian
G
G
Greenland
T
T
Vandenesch
F
F
Picot
S
S
D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage; D001203:Ascomycota / Q000302:isolation & purification*; D004696:Endocarditis / Q000175:diagnosis / Q000382:microbiology*; D006349:Heart Valve Diseases / Q000150:complications / Q000382:microbiology / Q000601:surgery; D006350:Heart Valve Prosthesis / Q000009:adverse effects / Q000382:microbiology*; D006801:Humans; D008297:Male; D008943:Mitral Valve; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis; D013211:Staphylococcus aureus / Q000302:isolation & purification; D016896:Treatment Outcome
D000935:Antifungal Agents